Skip to Main Content

Manufacturer Rebate Summary Report

CMS Drug Spending


Main Content

2014 Part D Rebate Summary for All Brand Name Drugs

Total Brand Name Drug Rebate1 Total Brand Name Drug Cost2 Rebate %
(of Total Brand Name Drug Cost)
$16,268,249,791 $92,954,130,307 17.5%

2014 Part D Brand Name Drug Rebate Summary by Therapeutic Class3

Drug Class3 Total Brand Name Drug Rebate1 Total Brand Name Drug Cost2 Rebate %
(of Class Total Brand Name Drug Cost)
Cardiovascular Drugs $2,868,830,328 $10,890,974,066 26.3%
Central Nervous System Agents $1,959,659,465 $15,042,684,392 13.0%
Hormones and Synthetic Substitutes $5,129,689,466 $20,532,619,261 25.0%
Miscellaneous Therapeutic Agents $1,177,101,010 $12,650,285,884 9.3%
All Other Classes $7,118,633,721 $46,835,503,748 15.2%

2014 Part D Rebate Summary for Brand Name Drugs in Medicare Drug Spending Dashboard

Total Brand Name Drug Rebate1 Total Brand Name Drug Cost2 Rebate %
(of Total Brand Name Drug Cost)
$6,594,230,823 $37,098,203,804 17.8%

1 Restricted to rebates associated with Part D drug events in calendar year 2014.  Excludes non-rebate amounts reported as "other direct and indirect remuneration." 

2 Based on the gross drug cost, which represents total spending for the prescription claim, including Medicare, plan, and beneficiary payments.             

3 Drug classes based on the American Hospital Formulary System (AHFS) level 2 drug categories.  These classes were chosen due to their broad inclusion of many drugs and many manufacturers.  A small number of drugs are included in multiple classes (e.g., combination drugs), thus class-level totals do not sum to the grand total.